Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Combined immunodeficiency due to dedicator of cytokinesis 8 protein (DOCK8) deficiency is a form of T and B cell immunodeficiency characterized by recurrent cutaneous viral infections, susceptibility to cancer and elevated serum levels of immunoglobulin E (IgE).
Features include always present findings: Decreased CD4+ T cell proportion, Recurrent bacterial infections, Decreased circulating total IgM, and Atopic dermatitis and others; and very common findings: Increased circulating IgE concentration, Cutaneous abscess, Increased total eosinophil count, and Food allergy and others. 38 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 7 | Autoimmunity, Recurrent bacterial infections, Recurrent sinopulmonary infections |
Lungs and breathing | 5 | Recurrent pneumonia, Pulmonary pneumatocele, Asthma |
Brain and nerves | 2 | Hemiplegia, Cerebral vasculitis |
Lab test results | 2 | Increased circulating IgE concentration, Increased circulating IgG concentration |
Growth and development | 2 | Failure to thrive, Growth delay |
Skin | 2 | Atopic dermatitis, Eczematoid dermatitis |
Digestive system | 1 | Eosinophilic infiltration of the esophagus |
Heart and blood vessels | 1 | Subarachnoid hemorrhage |
Bones and joints | 1 | Bone infection (osteomyelitis) |
Ears | 1 | Recurrent otitis media |
DOCK8 encodes dedicator of cytokinesis 8 (2,099 aa). Guanine nucleotide exchange factor (GEF) which specifically activates small GTPase CDC42 by exchanging bound GDP for free GTP. Highest expression in Spleen (49.4 TPM) and Cells EBV-transformed lymphocytes (49.0 TPM).
Combined immunodeficiency due to DOCK8 deficiency is caused by mutations in the DOCK8 gene on chromosome 9.
The DOCK8 protein participates in RHOJ GEFs activate RHOJ, CDC42 GEFs activate CDC42, and RAC1 GEFs activate RAC1 pathways.
DOCK8 is classified as a druggable target with score 0.6.
Genetic testing for DOCK8 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for combined immunodeficiency due to DOCK8 deficiency has been reported in the published literature.
Phenotype severity distribution: 5 always present features, 7 very common features, 9 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for combined immunodeficiency due to DOCK8 deficiency.
106 publications have been identified in PubMed for combined immunodeficiency due to DOCK8 deficiency. Research spans Epidemiology / Natural History (30%), Review / Meta-Analysis (27%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 30 | 30% |
Research summaries | 27 | 27% |
Laboratory research | 13 | 13% |
Patient case studies | 11 | 11% |
Clinical study results | 11 | 11% |
Testing and diagnosis research | 7 | 7% |
Other research | 1 | 1% |
Siniscalco ER (2026). [PMID: 41604592](https://pubmed.ncbi.nlm.nih.gov/41604592/). *J Exp Med*. [Basic Science / Preclinical]
Zhang X (2026). [PMID: 40886111](https://pubmed.ncbi.nlm.nih.gov/40886111/). *Postgrad Med J*. [Epidemiology / Natural History]
Khalid N (2026). [PMID: 32966010](https://pubmed.ncbi.nlm.nih.gov/32966010/). *Unknown Journal*. [Diagnostic / Biomarker]
Shaver N (2026). [PMID: 42233731](https://pubmed.ncbi.nlm.nih.gov/42233731/). *Work*. [Review / Meta-Analysis]
Fenner R (2026). [PMID: 41355466](https://pubmed.ncbi.nlm.nih.gov/41355466/). *Curr Opin Allergy Clin Immunol*. [Review / Meta-Analysis]
Teutsch D (2026). [PMID: 41571980](https://pubmed.ncbi.nlm.nih.gov/41571980/). *Med Klin Intensivmed Notfmed*. [Review / Meta-Analysis]
Feng X (2025). [PMID: 40938212](https://pubmed.ncbi.nlm.nih.gov/40938212/). *Adv Biol (Weinh)*. [Basic Science / Preclinical]
Chen X (2025). [PMID: 40600159](https://pubmed.ncbi.nlm.nih.gov/40600159/). *Front Public Health*. [Epidemiology / Natural History]
Cadena-Povea H (2025). [PMID: 40869800](https://pubmed.ncbi.nlm.nih.gov/40869800/). *Int J Environ Res Public Health*. [Review / Meta-Analysis]
Aliyeva G (2025). [PMID: 41099879](https://pubmed.ncbi.nlm.nih.gov/41099879/). *J Clin Immunol*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 6:51 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about combined immunodeficiency due to DOCK8 deficiency